Physician

Brian D Vicuna, MD

According to 2025 Medicare claims, Brian Vicuna, MD (NPI: 1275755670) practices hematology/oncology in the Las Vegas-Henderson-North Las Vegas, NV market, with the plurality of this provider's patient population coming from Clark, NV. This provider's primary affiliated billing organization is ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (NPI: 1598770471; TIN: 88-0350180) and primary practice location at 89144-9998.

Vicuna's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 908 traditional Medicare patients, billed 271,156 HCPCS/CPT codes, and received $3,859,504 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,929 prescription claims across 409 beneficiaries totaling $6,848,191 in drug costs, led by Erleada (Apalutamide). DME data shows 25 claims. Open Payments data shows 247 records totaling $152,951. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $902,864 to $6,848,191. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $8,628 to $788.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,112	214,661	$2,701,038
2016	1,127	252,740	$2,874,479
2017	1,200	267,866	$3,255,313
2018	1,148	322,225	$3,693,197
2019	823	235,378	$2,835,258
2020	816	246,458	$3,085,260
2021	758	212,314	$3,129,199
2022	909	266,944	$4,170,319
2023	925	264,791	$3,792,747
2024	908	271,156	$3,859,504

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	200	1,268	$902,864
2016	238	1,397	$1,155,568
2017	305	2,151	$2,546,197
2018	271	2,137	$2,928,362
2019	235	1,812	$2,607,713
2020	222	1,870	$2,593,058
2021	228	2,008	$2,681,859
2022	280	2,070	$3,624,758
2023	342	2,378	$4,912,345
2024	409	2,929	$6,848,191

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$7,192
2016	N/R	25	$1,548
2017	N/R	179	$70,151
2018	N/R	72	$17,402
2019	N/R	102	$5,878
2020	N/R	51	$4,226
2021	N/R	N/R	N/R
2022	N/R	18	$268
2023	N/R	12	$5,835
2024	N/R	25	$686

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	322	623	$98
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	310	398	$63
80053	Blood test, comprehensive group of blood chemicals	453	1,187	$10
36415	Insertion of needle into vein for collection of blood sample	491	1,417	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	498	1,569	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	63	1,950	$781,798
Ibrance	Palbociclib	41	1,148	$630,034
Xtandi	Enzalutamide	36	1,080	$484,062
Pomalyst	Pomalidomide	24	546	$432,603
Verzenio	Abemaciclib	28	784	$426,747

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$536
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	11	$150

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	183	$20,699	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	64	$132,252	Exelixis Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian D. Vicuna, MD?

Tedicare shows public-source Medicare data for Brian D. Vicuna, MD (NPI 1275755670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian D. Vicuna, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Brian D. Vicuna, MD?

Brian D. Vicuna, MD is linked to ALLISON CURTIS KINGSLEY MEOZ MICHAEL & SANCHEZ PC (billing NPI 1598770471) in the available physician profile data.

Does Brian D. Vicuna, MD have Open Payments data?

Brian D. Vicuna, MD has 247 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.